James Grichnik
Experienced in Telangiectasia

Dr. James Grichnik

Dermatology
Univ. Medical Service Association Inc.
13330 Usf Laurel Dr, 
Tampa, FL 
Offers Telehealth
Experienced in Telangiectasia
Univ. Medical Service Association Inc.
13330 Usf Laurel Dr, 
Tampa, FL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

James Grichnik is a Dermatologist in Tampa, Florida. Dr. Grichnik is rated as an Experienced provider by MediFind in the treatment of Telangiectasia. His top areas of expertise are Melanoma, Familial Atypical Multiple Mole Melanoma Syndrome, Seborrheic Keratosis, Cherry Angioma, and Tissue Biopsy.

His clinical research consists of co-authoring 64 peer reviewed articles and participating in 12 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Dermatology
Licenses
Dermatology in NC
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Florida Blue
  • EPO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Options
  • HMO
  • POS
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
Sunshine Health
  • EPO
  • HMO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 14 Less Insurance Carriers -

Locations

Univ. Medical Service Association Inc.
13330 Usf Laurel Dr, Tampa, FL 33612
Call: 813-974-4270

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

12 Clinical Trials

Randomized Study of Erlotinib Vs Observation in Patients With Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC)
Randomized Study of Erlotinib Vs Observation in Patients With Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC)
Enrollment Status: Active_not_recruiting
Publish Date: February 12, 2026
Intervention Type: Other, Drug
Study Drug: Erlotinib Hydrochloride
Study Phase: Phase 3
Molecular Analysis for Therapy Choice (MATCH)
Molecular Analysis for Therapy Choice (MATCH)
Enrollment Status: Active_not_recruiting
Publish Date: February 12, 2026
Intervention Type: Procedure, Drug, Other, Biological
Study Drugs: Adavosertib, Afatinib, Binimetinib, Capivasertib, Copanlisib, Crizotinib, Dabrafenib, Dasatinib, Defactinib, Erdafitinib, FGFR Inhibitor AZD4547, Ipatasertib, Larotrectinib, Nivolumab, Osimertinib, Palbociclib, Pertuzumab, PI3K-Beta Inhibitor GSK2636771, Sapanisertib, Sunitinib, Taselisib, Trametinib, Trastuzumab, Ulixertinib, Vismodegib
Study Phase: Phase 2
Adjuvant Nivolumab in Resected Lung Cancers (ANVIL)-A Randomized Phase III Study of Nivolumab After Surgical Resection and Adjuvant Chemotherapy in Non-Small Cell Lung Cancers
Adjuvant Nivolumab in Resected Lung Cancers (ANVIL)-A Randomized Phase III Study of Nivolumab After Surgical Resection and Adjuvant Chemotherapy in Non-Small Cell Lung Cancers
Enrollment Status: Active_not_recruiting
Publish Date: February 12, 2026
Intervention Type: Procedure, Biological, Other
Study Drug: Nivolumab
Study Phase: Phase 3
Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
Enrollment Status: Active_not_recruiting
Publish Date: February 12, 2026
Intervention Type: Other, Procedure, Biological, Drug
Study Phase: Not Applicable
The National Myelodysplastic Syndromes Natural History Study
The National Myelodysplastic Syndromes Natural History Study
Enrollment Status: Completed
Publish Date: February 03, 2026
Intervention Type: Other
A Randomized Phase III Trial for Surgically Resected Early Stage Non-small Cell Lung Cancer: Crizotinib Versus Observation for Patients With Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein
A Randomized Phase III Trial for Surgically Resected Early Stage Non-small Cell Lung Cancer: Crizotinib Versus Observation for Patients With Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein
Enrollment Status: Active_not_recruiting
Publish Date: December 19, 2025
Intervention Type: Other, Drug
Study Drug: Crizotinib
Study Phase: Phase 3
Phase II Trial of Atezolizumab in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Phase II Trial of Atezolizumab in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Enrollment Status: Completed
Publish Date: May 22, 2025
Intervention Type: Drug
Study Drug: Atezolizumab
Study Phase: Phase 2
Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer
Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: January 13, 2025
Intervention Type: Other
Study Phase: Phase 3
A Phase 3, 16-week, Randomized, Double-Blind, Placebo-Controlled, Parallel- Group Study to Assess the Impact of Lebrikizumab on Vaccine Responses in Adult Patients With Moderate-to-Severe Atopic Dermatitis
A Phase 3, 16-week, Randomized, Double-Blind, Placebo-Controlled, Parallel- Group Study to Assess the Impact of Lebrikizumab on Vaccine Responses in Adult Patients With Moderate-to-Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: October 17, 2023
Intervention Type: Drug
Study Drug: Lebrikizumab
Study Phase: Phase 3
A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for HER2 Negative Breast Cancer: The ABC Trial
A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for HER2 Negative Breast Cancer: The ABC Trial
Enrollment Status: Terminated
Publish Date: April 05, 2023
Intervention Type: Other, Drug
Study Drug: Aspirin
Study Phase: Phase 3
A Double Blind Randomized Vehicle Controlled Crossover Study to Evaluate the Safety and Efficacy of Topical Naloxone Hydrochloride Lotion 0.5% for the Relief of Pruritus in Patients With the MF or SS Forms of Cutaneous T-Cell Lymphoma
A Double Blind Randomized Vehicle Controlled Crossover Study to Evaluate the Safety and Efficacy of Topical Naloxone Hydrochloride Lotion 0.5% for the Relief of Pruritus in Patients With the MF or SS Forms of Cutaneous T-Cell Lymphoma
Enrollment Status: Terminated
Publish Date: October 28, 2022
Intervention Type: Drug
Study Drug: Naloxone Hydrochloride Lotion
Study Phase: Phase 3
Reducing Surgical Complications in Newly Diagnosed Lung Cancer Patients Who Smoke Cigarettes
Reducing Surgical Complications in Newly Diagnosed Lung Cancer Patients Who Smoke Cigarettes
Enrollment Status: Terminated
Publish Date: July 27, 2022
Intervention Type: Drug, Other
Study Drug: Varenicline
Study Phase: Phase 3
View 11 Less Clinical Trials

65 Total Publications

Topical cantharidin use in dermatology: an updated review.
Topical cantharidin use in dermatology: an updated review.
Journal: Dermatology online journal
Published: January 03, 2025
View All 65 Publications
Similar Doctors
Advanced in Telangiectasia
Dr. David Nathan
Dermatology
Advanced in Telangiectasia
Dr. David Nathan
Dermatology

Office

1016 Ponce De Leon Blvd Ste 7, 
Clearwater, FL 
 (24.3 miles away)
727-584-2131
Languages Spoken:
English
See accepted insurances

David Nathan is a Dermatologist in Clearwater, Florida. Dr. Nathan is rated as an Advanced provider by MediFind in the treatment of Telangiectasia. His top areas of expertise are Actinic Keratosis, Telangiectasia, Spider Angioma, and Seborrheic Keratosis.

Advanced in Telangiectasia
Dr. Timothy Kelly
Dermatology
Advanced in Telangiectasia
Dr. Timothy Kelly
Dermatology

PHDermatology Safety Harbor

1840 Mease Dr Ste 406, 
Safety Harbor, FL 
 (16.9 miles away)
727-712-8222
Languages Spoken:
English
See accepted insurances

Timothy Kelly is a Dermatologist in Safety Harbor, Florida. Dr. Kelly is rated as an Advanced provider by MediFind in the treatment of Telangiectasia. His top areas of expertise are Scalded Skin Syndrome, Kaposiform Hemangioendothelioma, Fetal Cystic Hygroma, and Spider Angioma.

Experienced in Telangiectasia
Dr. John Millns
Dermatology
Experienced in Telangiectasia
Dr. John Millns
Dermatology

Dermatology Associates Of Tampa Bay LLC

6001 Memorial Hwy, 
Tampa, FL 
 (10.8 miles away)
813-882-4206
Languages Spoken:
English
See accepted insurances

John Millns is a Dermatologist in Tampa, Florida. Dr. Millns is rated as an Experienced provider by MediFind in the treatment of Telangiectasia. His top areas of expertise are Telangiectasia, Spider Angioma, Neurocutaneous Melanosis, and Giant Congenital Melanocytic Nevus.

VIEW MORE TELANGIECTASIA DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Grichnik's expertise for a condition
ConditionClose
    • Distinguished
    • Familial Atypical Multiple Mole Melanoma Syndrome
      Dr. Grichnik is
      Distinguished
      . Learn about Familial Atypical Multiple Mole Melanoma Syndrome.
      See more Familial Atypical Multiple Mole Melanoma Syndrome experts
    • Melanoma
      Dr. Grichnik is
      Distinguished
      . Learn about Melanoma.
      See more Melanoma experts
    • Advanced
    • Actinic Keratosis
      Dr. Grichnik is
      Advanced
      . Learn about Actinic Keratosis.
      See more Actinic Keratosis experts
    • Basal Cell Skin Cancer
      Dr. Grichnik is
      Advanced
      . Learn about Basal Cell Skin Cancer.
      See more Basal Cell Skin Cancer experts
    • Cherry Angioma
      Dr. Grichnik is
      Advanced
      . Learn about Cherry Angioma.
      See more Cherry Angioma experts
    • Giant Congenital Melanocytic Nevus
      Dr. Grichnik is
      Advanced
      . Learn about Giant Congenital Melanocytic Nevus.
      See more Giant Congenital Melanocytic Nevus experts
    • Hemangioma
      Dr. Grichnik is
      Advanced
      . Learn about Hemangioma.
      See more Hemangioma experts
    • Melasma
      Dr. Grichnik is
      Advanced
      . Learn about Melasma.
      See more Melasma experts
    View All 9 Advanced Conditions
    • Experienced
    • Athlete's Foot
      Dr. Grichnik is
      Experienced
      . Learn about Athlete's Foot.
      See more Athlete's Foot experts
    • Bowen's Disease
      Dr. Grichnik is
      Experienced
      . Learn about Bowen's Disease.
      See more Bowen's Disease experts
    • Cerebral Cavernous Malformation
      Dr. Grichnik is
      Experienced
      . Learn about Cerebral Cavernous Malformation.
      See more Cerebral Cavernous Malformation experts
    • Cutaneous T-Cell Lymphoma (CTCL)
      Dr. Grichnik is
      Experienced
      . Learn about Cutaneous T-Cell Lymphoma (CTCL).
      See more Cutaneous T-Cell Lymphoma (CTCL) experts
    • Extramammary Paget Disease
      Dr. Grichnik is
      Experienced
      . Learn about Extramammary Paget Disease.
      See more Extramammary Paget Disease experts
    • Familial Multiple Nevi Flammei
      Dr. Grichnik is
      Experienced
      . Learn about Familial Multiple Nevi Flammei.
      See more Familial Multiple Nevi Flammei experts
    View All 31 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.